Opal Therapeutics

Opal Therapeutics is developing an innovative platform technology that integrates uterine organoids with AI analysis to discover non-hormonal, targeted drugs. This approach aims to improve outcomes for gynecological disorders and advance female-focused research, offering more effective and less invasive treatment options for women.